ID   TIE1_HUMAN              Reviewed;        1138 AA.
AC   P35590; B5A949; B5A950;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   10-MAY-2017, entry version 175.
DE   RecName: Full=Tyrosine-protein kinase receptor Tie-1;
DE            EC=2.7.10.1;
DE   Flags: Precursor;
GN   Name=TIE1; Synonyms=TIE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1312667; DOI=10.1128/MCB.12.4.1698;
RA   Partanen J., Armstrong E., Maekelae T.P., Korhonen J., Sandberg M.,
RA   Renkonen R., Knuutila S., Huebner K., Alitalo K.;
RT   "A novel endothelial cell surface receptor tyrosine kinase with
RT   extracellular epidermal growth factor homology domains.";
RL   Mol. Cell. Biol. 12:1698-1707(1992).
RN   [2]
RP   SEQUENCE REVISION.
RA   Partanen J.M.;
RL   Submitted (JUL-1993) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), AND ALTERNATIVE
RP   SPLICING.
RX   PubMed=18593464; DOI=10.1186/ar2447;
RA   Jin P., Zhang J., Sumariwalla P.F., Ni I., Jorgensen B., Crawford D.,
RA   Phillips S., Feldmann M., Shepard H.M., Paleolog E.M.;
RT   "Novel splice variants derived from the receptor tyrosine kinase
RT   superfamily are potential therapeutics for rheumatoid arthritis.";
RL   Arthritis Res. Ther. 10:R73-R73(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 22-36.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [7]
RP   INTERACTION WITH TEK/TIE2, SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=15851516; DOI=10.1083/jcb.200411105;
RA   Saharinen P., Kerkela K., Ekman N., Marron M., Brindle N., Lee G.M.,
RA   Augustin H., Koh G.Y., Alitalo K.;
RT   "Multiple angiopoietin recombinant proteins activate the Tie1 receptor
RT   tyrosine kinase and promote its interaction with Tie2.";
RL   J. Cell Biol. 169:239-243(2005).
RN   [8]
RP   INTERACTION WITH TEK/TIE2, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=20227369; DOI=10.1016/j.molcel.2010.02.007;
RA   Seegar T.C., Eller B., Tzvetkova-Robev D., Kolev M.V., Henderson S.C.,
RA   Nikolov D.B., Barton W.A.;
RT   "Tie1-Tie2 interactions mediate functional differences between
RT   angiopoietin ligands.";
RL   Mol. Cell 37:643-655(2010).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] MET-448; VAL-1104 AND HIS-1109.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Transmembrane tyrosine-protein kinase that may modulate
CC       TEK/TIE2 activity and contribute to the regulation of
CC       angiogenesis. {ECO:0000269|PubMed:20227369}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028}.
CC   -!- SUBUNIT: Heterodimer with TEK/TIE2.
CC   -!- INTERACTION:
CC       Q6A162:KRT40; NbExp=3; IntAct=EBI-2256865, EBI-10171697;
CC       Q15238:PSG5; NbExp=3; IntAct=EBI-2256865, EBI-4314891;
CC       Q93062:RBPMS; NbExp=3; IntAct=EBI-2256865, EBI-740322;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15851516,
CC       ECO:0000269|PubMed:20227369}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:15851516, ECO:0000269|PubMed:20227369}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P35590-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P35590-2; Sequence=VSP_047609, VSP_047610;
CC       Name=3;
CC         IsoId=P35590-3; Sequence=VSP_047607, VSP_047608;
CC   -!- TISSUE SPECIFICITY: Specifically expressed in developing vascular
CC       endothelial cells.
CC   -!- PTM: Phosphorylated on tyrosine residues in response to ANGPT1,
CC       most likely by TEK/TIE2. {ECO:0000269|PubMed:15851516}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Tie subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TIE1ID42560ch1p34.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X60957; CAA43290.1; -; mRNA.
DR   EMBL; EU826587; ACF47623.1; -; mRNA.
DR   EMBL; EU826588; ACF47624.1; -; mRNA.
DR   EMBL; AC093420; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL139289; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC038239; AAH38239.1; -; mRNA.
DR   CCDS; CCDS482.1; -. [P35590-1]
DR   RefSeq; NP_005415.1; NM_005424.4. [P35590-1]
DR   UniGene; Hs.78824; -.
DR   ProteinModelPortal; P35590; -.
DR   SMR; P35590; -.
DR   BioGrid; 112931; 8.
DR   IntAct; P35590; 13.
DR   MINT; MINT-6773015; -.
DR   STRING; 9606.ENSP00000361554; -.
DR   BindingDB; P35590; -.
DR   ChEMBL; CHEMBL5274; -.
DR   GuidetoPHARMACOLOGY; 1841; -.
DR   iPTMnet; P35590; -.
DR   PhosphoSitePlus; P35590; -.
DR   BioMuta; TIE1; -.
DR   DMDM; 549081; -.
DR   PaxDb; P35590; -.
DR   PeptideAtlas; P35590; -.
DR   PRIDE; P35590; -.
DR   DNASU; 7075; -.
DR   Ensembl; ENST00000372476; ENSP00000361554; ENSG00000066056. [P35590-1]
DR   Ensembl; ENST00000538015; ENSP00000440063; ENSG00000066056. [P35590-2]
DR   GeneID; 7075; -.
DR   KEGG; hsa:7075; -.
DR   UCSC; uc001ciu.4; human. [P35590-1]
DR   CTD; 7075; -.
DR   DisGeNET; 7075; -.
DR   GeneCards; TIE1; -.
DR   HGNC; HGNC:11809; TIE1.
DR   HPA; HPA045769; -.
DR   MIM; 600222; gene.
DR   neXtProt; NX_P35590; -.
DR   OpenTargets; ENSG00000066056; -.
DR   PharmGKB; PA36516; -.
DR   eggNOG; KOG0200; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00810000125384; -.
DR   HOGENOM; HOG000049232; -.
DR   HOVERGEN; HBG007316; -.
DR   InParanoid; P35590; -.
DR   KO; K05120; -.
DR   OMA; HNSPGAH; -.
DR   OrthoDB; EOG091G00RL; -.
DR   PhylomeDB; P35590; -.
DR   TreeFam; TF317568; -.
DR   BRENDA; 2.7.10.1; 2681.
DR   SignaLink; P35590; -.
DR   SIGNOR; P35590; -.
DR   ChiTaRS; TIE1; human.
DR   GenomeRNAi; 7075; -.
DR   PRO; PR:P35590; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000066056; -.
DR   CleanEx; HS_TIE1; -.
DR   Genevisible; P35590; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:ProtInc.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0007498; P:mesoderm development; TAS:ProtInc.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl.
DR   GO; GO:0030336; P:negative regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0045026; P:plasma membrane fusion; IEA:Ensembl.
DR   GO; GO:0032526; P:response to retinoic acid; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0001570; P:vasculogenesis; IEA:Ensembl.
DR   CDD; cd00063; FN3; 3.
DR   Gene3D; 2.60.40.10; -; 5.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013151; Immunoglobulin.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   Pfam; PF00041; fn3; 3.
DR   Pfam; PF00047; ig; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00181; EGF; 3.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00409; IG; 2.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF48726; SSF48726; 2.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00022; EGF_1; 3.
DR   PROSITE; PS01186; EGF_2; 3.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Angiogenesis; ATP-binding; Cell membrane;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   EGF-like domain; Glycoprotein; Immunoglobulin domain; Kinase;
KW   Membrane; Nucleotide-binding; Phosphoprotein; Polymorphism; Receptor;
KW   Reference proteome; Repeat; Signal; Transferase; Transmembrane;
KW   Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL        1     21       {ECO:0000269|PubMed:15340161}.
FT   CHAIN        22   1138       Tyrosine-protein kinase receptor Tie-1.
FT                                /FTId=PRO_0000024471.
FT   TOPO_DOM     22    759       Extracellular. {ECO:0000255}.
FT   TRANSMEM    760    784       Helical. {ECO:0000255}.
FT   TOPO_DOM    785   1138       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       43    105       Ig-like C2-type 1.
FT   DOMAIN      214    256       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      258    303       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      305    345       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      372    426       Ig-like C2-type 2.
FT   DOMAIN      446    545       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      548    642       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      646    739       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      839   1118       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     845    853       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    979    979       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     870    870       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES    1007   1007       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000250}.
FT   CARBOHYD     83     83       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    161    161       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    503    503       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    596    596       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    709    709       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    228    237       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    231    244       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    246    255       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    315    327       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    321    333       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    335    344       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   VAR_SEQ     305    317       ACAPGHFGADCRL -> VHQGHCGAREDHS (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:18593464}.
FT                                /FTId=VSP_047607.
FT   VAR_SEQ     318   1138       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:18593464}.
FT                                /FTId=VSP_047608.
FT   VAR_SEQ     348    379       DRIPQILNMASELEFNLETMPRINCAAAGNPF -> GWRDW
FT                                VDTSTEKQNTDEGRFGGHVSAPVGAPG (in isoform
FT                                2). {ECO:0000303|PubMed:18593464}.
FT                                /FTId=VSP_047609.
FT   VAR_SEQ     380   1138       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:18593464}.
FT                                /FTId=VSP_047610.
FT   VARIANT     448    448       V -> M (in dbSNP:rs56302794).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041852.
FT   VARIANT    1104   1104       A -> V (in dbSNP:rs35573981).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041853.
FT   VARIANT    1109   1109       R -> H (in dbSNP:rs34993202).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041854.
SQ   SEQUENCE   1138 AA;  125090 MW;  3B42BE33678C58A1 CRC64;
     MVWRVPPFLL PILFLASHVG AAVDLTLLAN LRLTDPQRFF LTCVSGEAGA GRGSDAWGPP
     LLLEKDDRIV RTPPGPPLRL ARNGSHQVTL RGFSKPSDLV GVFSCVGGAG ARRTRVIYVH
     NSPGAHLLPD KVTHTVNKGD TAVLSARVHK EKQTDVIWKS NGSYFYTLDW HEAQDGRFLL
     QLPNVQPPSS GIYSATYLEA SPLGSAFFRL IVRGCGAGRW GPGCTKECPG CLHGGVCHDH
     DGECVCPPGF TGTRCEQACR EGRFGQSCQE QCPGISGCRG LTFCLPDPYG CSCGSGWRGS
     QCQEACAPGH FGADCRLQCQ CQNGGTCDRF SGCVCPSGWH GVHCEKSDRI PQILNMASEL
     EFNLETMPRI NCAAAGNPFP VRGSIELRKP DGTVLLSTKA IVEPEKTTAE FEVPRLVLAD
     SGFWECRVST SGGQDSRRFK VNVKVPPVPL AAPRLLTKQS RQLVVSPLVS FSGDGPISTV
     RLHYRPQDST MDWSTIVVDP SENVTLMNLR PKTGYSVRVQ LSRPGEGGEG AWGPPTLMTT
     DCPEPLLQPW LEGWHVEGTD RLRVSWSLPL VPGPLVGDGF LLRLWDGTRG QERRENVSSP
     QARTALLTGL TPGTHYQLDV QLYHCTLLGP ASPPAHVLLP PSGPPAPRHL HAQALSDSEI
     QLTWKHPEAL PGPISKYVVE VQVAGGAGDP LWIDVDRPEE TSTIIRGLNA STRYLFRMRA
     SIQGLGDWSN TVEESTLGNG LQAEGPVQES RAAEEGLDQQ LILAVVGSVS ATCLTILAAL
     LTLVCIRRSC LHRRRTFTYQ SGSGEETILQ FSSGTLTLTR RPKLQPEPLS YPVLEWEDIT
     FEDLIGEGNF GQVIRAMIKK DGLKMNAAIK MLKEYASEND HRDFAGELEV LCKLGHHPNI
     INLLGACKNR GYLYIAIEYA PYGNLLDFLR KSRVLETDPA FAREHGTAST LSSRQLLRFA
     SDAANGMQYL SEKQFIHRDL AARNVLVGEN LASKIADFGL SRGEEVYVKK TMGRLPVRWM
     AIESLNYSVY TTKSDVWSFG VLLWEIVSLG GTPYCGMTCA ELYEKLPQGY RMEQPRNCDD
     EVYELMRQCW RDRPYERPPF AQIALQLGRM LEARKAYVNM SLFENFTYAG IDATAEEA
//
